Navigation Links
American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
Date:2/7/2008

hemicals accounted for 33% and 34% of our operations during the fiscal 2008 and 2007 first quarters, respectively. Fine Chemicals has grown as a percentage of total revenues, comprising 57% and 51% of consolidated revenues in the fiscal 2008 and 2007 first quarters, respectively.

In addition, our fiscal 2008 first quarter consolidated gross margin reflects:

-- Improvements in Specialty Chemicals segment gross margin percentage

driven by higher product volume.

-- A decrease in Fine Chemicals segment gross margin percentage relating

to a change in product mix.

-- An increase in Aerospace Equipment segment gross margin percentage.

See further discussion under our Segment Highlights.

Operating Expenses -- For our fiscal 2008 first quarter, operating expenses increased $1.7 million to $10.2 million from $8.5 million in the first quarter of fiscal year 2007, primarily due to:

-- An increase in Specialty Chemicals segment operating expenses of

$0.4 million primarily due to environmental related costs and employee

compensation.

-- An increase in Fine Chemicals segment operating expenses of

$0.5 million due to additional personnel costs, primarily recruiting

and relocation expenses.

-- An increase in corporate operating expenses of $0.7 million due to a

$0.6 million increase in employee compensation and retirement benefit

expenses and a $0.3 million increase in Sarbanes-Oxley compliance

costs, offset somewhat by numerous other minor decreases in corporate

operating expenses.

SEGMENT HIGHLIGHTS

Specialty Chemicals Segment Our Specialty Chemicals segment revenues include the operating results from our perchlorate, sodium azide and Halotron product lines, with perchlorates comprising 95% and 85% of Specialty Chemicals revenues in the fiscal 2008 and 2007 first quarters, respectively.

Quarter E
'/>"/>

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...e government still mulling over the inclusion of g...edges, a tobacco company has raised the ire of ant...f cigarettes in tins which carry health warnings i...sily removed. Action on Smoking and Health (ASH)...
...o are on oral bisphosphonates, a treatment measure...nd Paget's disease of bone, should be told about t...e , according to guidelines published in this mont...ociation (ADA). Relying on a small but growing n...
... of women, especially moms, suffer from stress uri...g, coughing or even laughing can lead to urine lea...ve therapies, such as learning better bladder habi...sing problems such as chronic coughing, infections...
...ty of North Carolina researchers have found that D...hampoos and other personal care products//, seems ... mice. The ingredient was applied to the skin of p...verse effect on their offspring. Dr. Steven Zeisel...
Other Medicine News:
(Date:10/8/2008)...e, Oct. 8 /- Vical Incorporated (Nasd...data and new nonclinical data,demonstrating that t...applicable in DNA- and protein-based infectious di...Alain P. Rolland, Pharm.D., Ph.D., Vical,s,Senior ...t the data today,Wednesday, October 8, at the Wor...
(Date:10/7/2008)...as, Oct. 7 /- The Texas Cardiac Arrhy...er has been selected as one of,only a few sites in...ical,trial for a new device to treat persistent at...t, training and research center specializing in he... David,s Medical Center and,Texas Cardiovascular C...
(Date:10/7/2008)...al study of adults, VYVANSE taken once-daily signi...week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCall/...l specialty biopharmaceutical company, today,annou... of the Journal of,Clinical Psychiatry found once-...icit Hyperactivity Disorder (ADHD) symptoms in adu...
(Date:10/7/2008)...tracts highlighting CIMZIA,s long-term benefits an...ents presented at American College,of Gastroentero...tCall/ -- Data from two studies,presented this wee...gy,(ACG) Annual Meeting demonstrate that CIMZIA(R)...F alpha (Tumor Necrosis Factor alpha) - provides,s...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9New study sheds light on Gal 26 23225 3Bpagos hawk evolutionary history 641 1New study sheds light on Gal 26 23225 3Bpagos hawk evolutionary history 641 2First significant genetic finding in severe PMS or PMDD 2600 1First significant genetic finding in severe PMS or PMDD 2600 2Algorithms to reanimate the heart 2598 1Algorithms to reanimate the heart 2598 2Algorithms to reanimate the heart 2598 3Dietary calcium could possibly prevent the spread of breast cancer to bone 639 1Dietary calcium could possibly prevent the spread of breast cancer to bone 639 2
...SINESS WIRE)--Jun 25, 2007 - Neurogen,Corporation ...esults from two dose-ranging, Phase 2b clinical tr...,s proprietary insomnia agent,NG2-73, an alpha-3 ...lations were studied in each trial to determine th...ntenance of sleep,through the night without residu...
...hly potent DPP-4 inhibitor, possessing Ki of 27,pM...armaceuticals,Inc., a privately held drug discove...results of its potent, smart DPP-4 inhibitor,ARI-...n Diabetes,Association meeting in Chicago, Illinoi...y long acting, potent inhibitor of DPP-4 and,produ...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4
... your own cath lab? Worried about the high costs,...adaches of managing the ongoing business operation... service leaving you free to care for your patient...venient diagnostic facility for you and your patie...
...s exactly the same as the model SP-8800 with one b...achy mode. This mode has its own fixation targets .... It allows you to select an area on the cornea to...are to calculate averages of multiple readings in ...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
Medicine Products: